INDIVINA

This brand name is authorized in Estonia, Finland, Germany, Ireland, Poland, UK.

Active ingredients

The drug INDIVINA contains a combination of these active pharmaceutical ingredients (APIs):

1	Estradiol UNII OKG364O896 - ESTRADIOL VALERATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol
2	Medroxyprogesterone UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FA12	Medroxyprogesterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01561284, 01561309, 01561350
EE	Ravimiamet	1618602, 1680667
FI	Lääkealan turvallisuus- ja kehittämiskeskus	575290, 575449, 575738
GB	Medicines & Healthcare Products Regulatory Agency	142538, 161920, 161922, 161924, 37800, 37803, 38538
IE	Health Products Regulatory Authority	29020, 29032, 29054, 29096
PL	Rejestru Produktów Leczniczych	100124265, 100124294, 100124319